NCBI . NLM . NIH . GOV {}

Matching Content Categories {📚}

• Health & Fitness
• Science
• Education

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We can't tell how the site generates income.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Ncbi.nlm.nih.gov might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

erlotinib, patients, gefitinib, cancer, lung, egfrtki, google, scholar, doi, disease, pubmed, study, adenocarcinoma, egfrtkis, survival, year, previously, received, analysis, pfs, cachexia, factor, duration, cohort, nsclc, chemotherapy, days, treatment, egfr, months, results, hospitalization, therapy, epidermal, growth, transfusion, advanced, national, treated, cox, regression, secondline, responders, pulmonary, ipsw, kinase, clinical, adjustment, clin, oncol,

Topics {✒️}

egfr‐tyrosine kinase inhibitors org/professionals/physician_gls/pdf/nscl tw/english/webdata/webdata menu=11&menu_id=296&webdata_id=1942&wd_id=296 small‐cell lung cancer �small‐cell lung cancer wild‐type egfr tumours 1‐year progression‐free survival started egfr‐tkis earlier kaplan–meier analysis revealed advanced egfr mutation‐positive egfr‐tkis remains debatable pmc beta search �generation efgr‐tkis varies facile diagnosis‐specific tool egfr‐tki responders exhibited platinum‐based doublet chemotherapy early‐stage lung cancer powerful prognostic factor independent prognostic factor tumor/plasma concentration ratio search included gemcitabine multivariate cox analysis end‐stage renal disease randomized control trials national health insurance jen‐chung ko 1 publisher site pdf egfr‐tki respondera erlotinib egfr‐tki adherent population identify low‐income earners cox regression analyses national cancer institute single‐agent chemotherapy advanced lung cancer egfr gene mutation lih‐yu chang 1 comprehensive molecular profiling tumor tissue concentration previously treated patients primary care physicians propensity score calculation propensity score methods egfr mutation status egfr mutation rate independent prognostic factors reach tumor cells small sample sizes license information pmcid institutional review board

Questions {❓}

• Epidermal growth factor receptor tyrosine kinase inhibitors: similar but different?

Social Networks {👍}(6)

• https://twitter.com/ncbi
• https://www.facebook.com/ncbi.nlm
• https://www.linkedin.com/company/ncbinlm
• https://twitter.com/nlm_nih
• https://www.facebook.com/nationallibraryofmedicine
• https://www.youtube.com/user/NLMNIH

External Links {🔗}(83)

• What's the financial outcome of https://doi.org/10.1002/cam4.1121?
• Financial intake of http://creativecommons.org/licenses/by/4.0/
• How much income does https://doi.org/10.3322/caac.21332 have?
• What's the total monthly financial gain of https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J.%20Clin.&title=Cancer%20statistics,%202016&author=R.%20L.%20Siegel&author=K.%20D.%20Miller&author=A.%20Jemal&volume=66&publication_year=2016&pages=7-30&pmid=26742998&doi=10.3322/caac.21332&?
• How much does https://doi.org/10.1038/nature13385 make?
• Explore the financials of https://scholar.google.com/scholar_lookup?journal=Nature&volume=511&publication_year=2014&pages=543-550&pmid=25079552&doi=10.1038/nature13385&
• Monthly income for https://doi.org/10.1097/JTO.0000000000000516
• What are the total earnings of https://scholar.google.com/scholar_lookup?journal=J.%20Thorac.%20Oncol.&title=Multi%E2%80%90institutional%20oncogenic%20driver%20mutation%20analysis%20in%20lung%20adenocarcinoma:%20the%20lung%20cancer%20mutation%20consortium%20experience&author=L.%20M.%20Sholl&author=D.%20L.%20Aisner&author=M.%20Varella%E2%80%90Garcia&author=L.%20D.%20Berry&author=D.%20Dias%E2%80%90Santagata&volume=10&publication_year=2015&pages=768-777&pmid=25738220&doi=10.1097/JTO.0000000000000516&?
• Get to know what's the income of https://doi.org/10.1056/NEJMoa0810699
• What's the financial outcome of https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&title=Gefitinib%20or%20carboplatin%E2%80%90paclitaxel%20in%20pulmonary%20adenocarcinoma&author=T.%20S.%20Mok&author=Y.%20L.%20Wu&author=S.%20Thongprasert&author=C.%20H.%20Yang&author=D.%20T.%20Chu&volume=361&publication_year=2009&pages=947-957&pmid=19692680&doi=10.1056/NEJMoa0810699&?
• Learn about the earnings of https://doi.org/10.1016/S1470-2045(11)70393-X
• https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol.&title=Erlotinib%20versus%20standard%20chemotherapy%20as%20first%E2%80%90line%20treatment%20for%20European%20patients%20with%20advanced%20EGFR%20mutation%E2%80%90positive%20non%E2%80%90small%E2%80%90cell%20lung%20cancer%20(EURTAC):%20a%20multicentre,%20open%E2%80%90label,%20randomised%20phase%203%20trial&author=R.%20Rosell&author=E.%20Carcereny&author=R.%20Gervais&author=A.%20Vergnenegre&author=B.%20Massuti&volume=13&publication_year=2012&pages=239-246&pmid=22285168&doi=10.1016/S1470-2045(11)70393-X&'s revenue stream
• https://doi.org/10.1056/NEJMoa050753's financial summary
• What's the monthly money flow for https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&title=Erlotinib%20in%20previously%20treated%20non%E2%80%90small%E2%80%90cell%20lung%20cancer&author=F.%20A.%20Shepherd&author=J.%20Rodrigues%20Pereira&author=T.%20Ciuleanu&author=E.%20H.%20Tan&author=V.%20Hirsh&volume=353&publication_year=2005&pages=123-132&pmid=16014882&doi=10.1056/NEJMoa050753&?
• How much does https://doi.org/10.1016/S0140-6736(05)67625-8 earn?
• Earnings of https://scholar.google.com/scholar_lookup?journal=Lancet&title=Gefitinib%20plus%20best%20supportive%20care%20in%20previously%20treated%20patients%20with%20refractory%20advanced%20non%E2%80%90small%E2%80%90cell%20lung%20cancer:%20results%20from%20a%20randomised,%20placebo%E2%80%90controlled,%20multicentre%20study%20(Iressa%20Survival%20Evaluation%20in%20Lung%20Cancer)&author=N.%20Thatcher&author=A.%20Chang&author=P.%20Parikh&author=J.%20Rodrigues%20Pereira&author=T.%20Ciuleanu&volume=366&publication_year=2005&pages=1527-1537&pmid=16257339&doi=10.1016/S0140-6736(05)67625-8&
• What is the earnings of https://doi.org/10.1200/JCO.2015.63.4154?
• Revenue of https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&title=Randomized%20phase%20III%20study%20comparing%20gefitinib%20with%20erlotinib%20in%20patients%20with%20previously%20treated%20advanced%20lung%20adenocarcinoma:%20WJOG%205108L&author=Y.%20Urata&author=N.%20Katakami&author=S.%20Morita&author=R.%20Kaji&author=H.%20Yoshioka&volume=34&publication_year=2016&pages=3248-3257&pmid=27022112&doi=10.1200/JCO.2015.63.4154&
• Monthly income for http://misc.medscape.com/images/586/420/nscl.pdf
• What's the financial intake of http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=296&webdata_id=1942&WD_ID=296?
• What's the monthly money flow for https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf?
• What's the monthly income of https://scholar.google.com/scholar_lookup?title=Guidelines%20for%20ATC%20classification%20and%20DDD%20assignment&publication_year=2011&?
• Learn how profitable https://doi.org/10.1093/jnci/92.3.205 is on a monthly basis
• https://scholar.google.com/scholar_lookup?journal=J.%20Natl%20Cancer%20Inst.&title=New%20guidelines%20to%20evaluate%20the%20response%20to%20treatment%20in%20solid%20tumors.%20European%20Organization%20for%20Research%20and%20Treatment%20of%20Cancer,%20National%20Cancer%20Institute%20of%20the%20United%20States,%20National%20Cancer%20Institute%20of%20Canada&author=P.%20Therasse&author=S.%20G.%20Arbuck&author=E.%20A.%20Eisenhauer&author=J.%20Wanders&author=R.%20S.%20Kaplan&volume=92&publication_year=2000&pages=205-216&pmid=10655437&doi=10.1093/jnci/92.3.205&'s total income per month
• Revenue of https://doi.org/10.1371/journal.pone.0037978
• Revenue of https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&title=Pulmonary%20tuberculosis%20and%20delay%20in%20anti%E2%80%90tuberculous%20treatment%20are%20important%20risk%20factors%20for%20chronic%20obstructive%20pulmonary%20disease&author=C.%20H.%20Lee&author=M.%20C.%20Lee&author=H.%20H.%20Lin&author=C.%20C.%20Shu&author=J.%20Y.%20Wang&volume=7&publication_year=2012&pages=e37978&pmid=22662259&doi=10.1371/journal.pone.0037978&
• https://doi.org/10.1200/JCO.2012.45.2722's financial summary
• Income figures for https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&title=Cancer%20cachexia%20in%20the%20age%20of%20obesity:%20skeletal%20muscle%20depletion%20is%20a%20powerful%20prognostic%20factor,%20independent%20of%20body%20mass%20index&author=L.%20Martin&author=L.%20Birdsell&author=N.%20Macdonald&author=T.%20Reiman&author=M.%20T.%20Clandinin&volume=31&publication_year=2013&pages=1539-1547&pmid=23530101&doi=10.1200/JCO.2012.45.2722&
• How much does https://doi.org/10.1200/JCO.2011.38.0527 make?
• Financial intake of https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&title=Summary%20report%20on%20the%20graded%20prognostic%20assessment:%20an%20accurate%20and%20facile%20diagnosis%E2%80%90specific%20tool%20to%20estimate%20survival%20for%20patients%20with%20brain%20metastases&author=P.%20W.%20Sperduto&author=N.%20Kased&author=D.%20Roberge&author=Z.%20Xu&author=R.%20Shanley&volume=30&publication_year=2012&pages=419-425&pmid=22203767&doi=10.1200/JCO.2011.38.0527&
• https://scholar.google.com/scholar_lookup?journal=Cancer&title=Anemia%20as%20an%20independent%20prognostic%20factor%20for%20survival%20in%20patients%20with%20cancer:%20a%20systemic,%20quantitative%20review&author=J.%20J.%20Caro&author=M.%20Salas&author=A.%20Ward&author=G.%20Goss&volume=91&publication_year=2001&pages=2214-2221&pmid=11413508&'s financial summary
• How profitable is https://doi.org/10.1080/00273171.2011.568786?
• What is the monthly revenue of https://scholar.google.com/scholar_lookup?journal=Multivar.%20Behav.%20Res.&title=An%20Introduction%20to%20Propensity%20Score%20Methods%20for%20Reducing%20the%20Effects%20of%20Confounding%20in%20Observational%20Studies&author=P.%20C.%20Austin&volume=46&publication_year=2011&pages=399-424&pmid=21818162&doi=10.1080/00273171.2011.568786&?
• How much money does https://doi.org/10.1001/jamaoncol.2016.1291 make?
• Explore the financials of https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol.&title=Nonadherence%20to%20medications%20for%20chronic%20conditions%20and%20nonadherence%20to%20adjuvant%20hormonal%20therapy%20in%20women%20with%20breast%20cancer&author=A.%20I.%20Neugut&author=X.%20Zhong&author=J.%20D.%20Wright&author=M.%20Accordino&author=J.%20Yang&volume=2&publication_year=2016&pages=1326-1332&pmid=27281650&doi=10.1001/jamaoncol.2016.1291&
• How much profit does https://doi.org/10.1016/S0140-6736(08)61758-4 make?
• How much income does https://scholar.google.com/scholar_lookup?journal=Lancet&title=Gefitinib%20versus%20docetaxel%20in%20previously%20treated%20non%E2%80%90small%E2%80%90cell%20lung%20cancer%20(INTEREST):%20a%20randomised%20phase%20III%20trial&author=E.%20S.%20Kim&author=V.%20Hirsh&author=T.%20Mok&author=M.%20A.%20Socinski&author=R.%20Gervais&volume=372&publication_year=2008&pages=1809-1818&pmid=19027483&doi=10.1016/S0140-6736(08)61758-4& have?
• What's the revenue for https://doi.org/10.1200/JCO.2007.15.0185?
• How much does https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&title=Phase%20III%20study,%20V%E2%80%9015%E2%80%9032,%20of%20gefitinib%20versus%20docetaxel%20in%20previously%20treated%20Japanese%20patients%20with%20non%E2%80%90small%E2%80%90cell%20lung%20cancer&author=R.%20Maruyama&author=Y.%20Nishiwaki&author=T.%20Tamura&author=N.%20Yamamoto&author=M.%20Tsuboi&volume=26&publication_year=2008&pages=4244-4252&pmid=18779611&doi=10.1200/JCO.2007.15.0185& rake in every month?
• Explore the financials of https://doi.org/10.1016/S1470-2045(11)70385-0
• Earnings of https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol.&title=Efficacy%20and%20safety%20of%20erlotinib%20versus%20chemotherapy%20in%20second%E2%80%90line%20treatment%20of%20patients%20with%20advanced,%20non%E2%80%90small%E2%80%90cell%20lung%20cancer%20with%20poor%20prognosis%20(TITAN):%20a%20randomised%20multicentre,%20open%E2%80%90label,%20phase%203%20study&author=T.%20Ciuleanu&author=L.%20Stelmakh&author=S.%20Cicenas&author=S.%20Miliauskas&author=A.%20C.%20Grigorescu&volume=13&publication_year=2012&pages=300-308&pmid=22277837&doi=10.1016/S1470-2045(11)70385-0&
• https://doi.org/10.1016/S1470-2045(13)70310-3's total income per month
• What's the financial outcome of https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol.&title=Erlotinib%20versus%20docetaxel%20as%20second%E2%80%90line%20treatment%20of%20patients%20with%20advanced%20non%E2%80%90small%E2%80%90cell%20lung%20cancer%20and%20wild%E2%80%90type%20EGFR%20tumours%20(TAILOR):%20a%20randomised%20controlled%20trial&author=M.%20C.%20Garassino&author=O.%20Martelli&author=M.%20Broggini&author=G.%20Farina&author=S.%20Veronese&volume=14&publication_year=2013&pages=981-988&pmid=23883922&doi=10.1016/S1470-2045(13)70310-3&?
• What's the monthly income of https://doi.org/10.1002/cncr.25130?
• See how much https://scholar.google.com/scholar_lookup?journal=Cancer&title=Comparison%20of%20gefitinib%20versus%20erlotinib%20in%20patients%20with%20nonsmall%20cell%20lung%20cancer%20who%20failed%20previous%20chemotherapy&author=S.%20T.%20Kim&author=J.%20Lee&author=J.%20H.%20Kim&author=Y.%20W.%20Won&author=J.%20M.%20Sun&volume=116&publication_year=2010&pages=3025-3033&pmid=20564408&doi=10.1002/cncr.25130& makes per month
• How much money does https://doi.org/10.1016/j.lungcan.2010.08.013 generate?
• https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer&title=Comparison%20of%20gefitinib%20and%20erlotinib%20in%20advanced%20NSCLC%20and%20the%20effect%20of%20EGFR%20mutations&author=J.%20Y.%20Wu&author=S.%20G.%20Wu&author=C.%20H.%20Yang&author=Y.%20L.%20Chang&author=Y.%20C.%20Chang&volume=72&publication_year=2011&pages=205-212&pmid=20832137&doi=10.1016/j.lungcan.2010.08.013&'s financial summary
• What's the revenue for https://doi.org/10.1097/JTO.0000000000000095?
• How much does https://scholar.google.com/scholar_lookup?journal=J.%20Thorac.%20Oncol.&title=Comparison%20of%20clinical%20outcomes%20following%20gefitinib%20and%20erlotinib%20treatment%20in%20non%E2%80%90small%E2%80%90cell%20lung%20cancer%20patients%20harboring%20an%20epidermal%20growth%20factor%20receptor%20mutation%20in%20either%20exon%2019%20or%2021&author=S.%20H.%20Lim&author=J.%20Y.%20Lee&author=J.%20M.%20Sun&author=J.%20S.%20Ahn&author=K.%20Park&volume=9&publication_year=2014&pages=506-511&pmid=24736073&doi=10.1097/JTO.0000000000000095& bring in each month?
• What's the total monthly financial gain of https://doi.org/10.1200/JCO.2001.19.13.3267?
• How much cash flow does https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&title=Phase%20I%20and%20pharmacologic%20study%20of%20OSI%E2%80%90774,%20an%20epidermal%20growth%20factor%20receptor%20tyrosine%20kinase%20inhibitor,%20in%20patients%20with%20advanced%20solid%20malignancies&author=M.%20Hidalgo&author=L.%20L.%20Siu&author=J.%20Nemunaitis&author=J.%20Rizzo&author=L.%20A.%20Hammond&volume=19&publication_year=2001&pages=3267-3279&pmid=11432895&doi=10.1200/JCO.2001.19.13.3267& have monthly?
• Monthly income for https://doi.org/10.1200/JCO.2002.03.100
• Income figures for https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&title=Phase%20I%20safety,%20pharmacokinetic,%20and%20pharmacodynamic%20trial%20of%20ZD1839,%20a%20selective%20oral%20epidermal%20growth%20factor%20receptor%20tyrosine%20kinase%20inhibitor,%20in%20patients%20with%20five%20selected%20solid%20tumor%20types&author=J.%20Baselga&author=D.%20Rischin&author=M.%20Ranson&author=H.%20Calvert&author=E.%20Raymond&volume=20&publication_year=2002&pages=4292-4302&pmid=12409327&doi=10.1200/JCO.2002.03.100&
• Learn about the earnings of https://doi.org/10.1634/theoncologist.10-8-579
• What is the earnings of https://scholar.google.com/scholar_lookup?journal=Oncologist.&title=Current%20knowledge%20and%20future%20directions%20of%20the%20selective%20epidermal%20growth%20factor%20receptor%20inhibitors%20erlotinib%20(Tarceva)%20and%20gefitinib%20(Iressa)&author=W.%20S.%20Siegel%E2%80%90Lakhai&author=J.%20H.%20Beijnen&author=J.%20H.%20Schellens&volume=10&publication_year=2005&pages=579-589&pmid=16177282&doi=10.1634/theoncologist.10-8-579&?
• Monthly income for https://doi.org/10.1158/1078-0432.CCR-04-0058
• How much money does https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&title=Development%20of%20the%20novel%20biologically%20targeted%20anticancer%20agent%20gefitinib:%20determining%20the%20optimum%20dose%20for%20clinical%20efficacy&author=M.%20Wolf&author=H.%20Swaisland&author=S.%20Averbuch&volume=10&publication_year=2004&pages=4607-4613&pmid=15269131&doi=10.1158/1078-0432.CCR-04-0058& generate?
• How much cash flow does https://doi.org/10.2165/00003088-200544110-00004 have monthly?
• What's the monthly income of https://scholar.google.com/scholar_lookup?journal=Clin.%20Pharmacokinet.&title=Single%E2%80%90dose%20clinical%20pharmacokinetic%20studies%20of%20gefitinib&author=H.%20C.%20Swaisland&author=R.%20P.%20Smith&author=A.%20Laight&author=D.%20J.%20Kerr&author=M.%20Ranson&volume=44&publication_year=2005&pages=1165-1177&pmid=16231967&doi=10.2165/00003088-200544110-00004&?
• Get to know what's the income of https://doi.org/10.1016/j.clpt.2006.04.007
• How profitable is https://scholar.google.com/scholar_lookup?journal=Clin.%20Pharmacol.%20Ther.&title=Clinical%20pharmacokinetics%20of%20erlotinib%20in%20patients%20with%20solid%20tumors%20and%20exposure%E2%80%90safety%20relationship%20in%20patients%20with%20non%E2%80%90small%20cell%20lung%20cancer&author=J.%20F.%20Lu&author=S.%20M.%20Eppler&author=J.%20Wolf&author=M.%20Hamilton&author=A.%20Rakhit&volume=80&publication_year=2006&pages=136-145&pmid=16890575&doi=10.1016/j.clpt.2006.04.007&?
• What's the profit of https://doi.org/10.1097/CAD.0b013e32833034e1?
• Get to know what's the income of https://scholar.google.com/scholar_lookup?journal=Anticancer%20Drugs&title=Epidermal%20growth%20factor%20receptor%20tyrosine%20kinase%20inhibitors:%20similar%20but%20different?&author=Y.%20Rukazenkov&author=G.%20Speake&author=G.%20Marshall&author=J.%20Anderton&author=B.%20R.%20Davies&volume=20&publication_year=2009&pages=856-866&pmid=19657272&doi=10.1097/CAD.0b013e32833034e1&
• Income figures for https://doi.org/10.1158/1078-0432.CCR-04-1169
• https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&title=Epidermal%20growth%20factor%20receptor%20tyrosine%20kinase%20inhibition%20represses%20cyclin%20D1%20in%20aerodigestive%20tract%20cancers&author=W.%20J.%20Petty&author=K.%20H.%20Dragnev&author=V.%20A.%20Memoli&author=Y.%20Ma&author=N.%20B.%20Desai&volume=10&publication_year=2004&pages=7547-7554&pmid=15569985&doi=10.1158/1078-0432.CCR-04-1169&'s financial summary
• Find out how much https://doi.org/10.1158/1078-0432.CCR-07-0088 earns monthly
• Learn about the earnings of https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&title=Differential%20metabolism%20of%20gefitinib%20and%20erlotinib%20by%20human%20cytochrome%20P450%20enzymes&author=J.%20Li&author=M.%20Zhao&author=P.%20He&author=M.%20Hidalgo&author=S.%20D.%20Baker&volume=13&publication_year=2007&pages=3731-3737&pmid=17575239&doi=10.1158/1078-0432.CCR-07-0088&
• What's https://doi.org/10.1158/1078-0432.CCR-05-2235's gross income?
• What's the financial gain of https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&title=Effects%20of%20smoking%20on%20the%20pharmacokinetics%20of%20erlotinib&author=M.%20Hamilton&author=J.%20L.%20Wolf&author=J.%20Rusk&author=S.%20E.%20Beard&author=G.%20M.%20Clark&volume=12&publication_year=2006&pages=2166-2171&pmid=16609030&doi=10.1158/1078-0432.CCR-05-2235&?
• Get to know https://doi.org/10.1097/JTO.0000000000000033's earnings
• How much profit does https://scholar.google.com/scholar_lookup?journal=J.%20Thorac.%20Oncol.&title=A%20prospective,%20molecular%20epidemiology%20study%20of%20EGFR%20mutations%20in%20Asian%20patients%20with%20advanced%20non%E2%80%90small%E2%80%90cell%20lung%20cancer%20of%20adenocarcinoma%20histology%20(PIONEER)&author=Y.%20Shi&author=J.%20S.%20Au&author=S.%20Thongprasert&author=S.%20Srinivasan&author=C.%20M.%20Tsai&volume=9&publication_year=2014&pages=154-162&pmid=24419411&doi=10.1097/JTO.0000000000000033& make?
• What's the financial intake of https://github.com/ncbi?
• How much cash flow does https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508, -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508! 4d-77.0988323 have monthly?
• How much does https://www.nlm.nih.gov/web_policies.html pull in monthly?
• How much money does https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office make?
• What's the financial intake of https://www.hhs.gov/vulnerability-disclosure-policy/index.html?
• How much does https://support.nlm.nih.gov/?pagename=cloudpmc-viewer%3Apmc%3Aarticle%3Ajournal pull in monthly?
• What's the monthly money flow for https://www.nlm.nih.gov/accessibility.html?
• What is the monthly revenue of https://www.nlm.nih.gov/careers/careers.html?
• What's the monthly income of https://www.nlm.nih.gov/?
• Learn about the earnings of https://www.nih.gov/
• What is the earnings of https://www.hhs.gov/?
• What's the monthly money flow for https://www.usa.gov/?

Analytics and Tracking {📊}

• Google Analytics
• Google Analytics 4
• Google Tag Manager

Libraries {📚}

• jQuery
• jQuery module (jquery-3.6.0)

Emails and Hosting {✉️}

Mail Servers:

• nihcesxway.hub.nih.gov
• nihcesxway2.hub.nih.gov
• nihcesxway3.hub.nih.gov
• nihcesxway4.hub.nih.gov
• nihcesxway5.hub.nih.gov

Name Servers:

• dns1-ncbi.ncbi.nlm.nih.gov
• dns2-ncbi.ncbi.nlm.nih.gov
• lhcns1.nlm.nih.gov
• lhcns2.nlm.nih.gov

CDN Services {📦}

• Ncbi